• This record comes from PubMed

Engineering the Pseudomonas aeruginosa II lectin: designing mutants with changed affinity and specificity

. 2014 Sep ; 28 (9) : 951-60. [epub] 20140712

Language English Country Netherlands Media print-electronic

Document type Journal Article, Research Support, Non-U.S. Gov't

This article focuses on designing mutations of the PA-IIL lectin from Pseudomonas aeruginosa that lead to change in specificity. Following the previous results revealing the importance of the amino acid triad 22-23-24 (so-called specificity-binding loop), saturation in silico mutagenesis was performed, with the intent of finding mutations that increase the lectin's affinity and modify its specificity. For that purpose, a combination of docking, molecular dynamics and binding free energy calculation was used. The combination of methods revealed mutations that changed the performance of the wild-type lectin and its mutants to their preferred partners. The mutation at position 22 resulted in 85% in inactivation of the binding site, and the mutation at 23 did not have strong effects thanks to the side chain being pointed away from the binding site. Molecular dynamics simulations followed by binding free energy calculation were performed on mutants with promising results from docking, and also at those where the amino acid at position 24 was replaced for bulkier or longer polar chain. The key mutants were also prepared in vitro and their binding properties determined by isothermal titration calorimetry. Combination of the used methods proved to be able to predict changes in the lectin performance and helped in explaining the data observed experimentally.

See more in PubMed

J Comput Chem. 2005 Dec;26(16):1668-88 PubMed

Biochemistry. 2009 Feb 3;48(4):786-91 PubMed

J Chem Inf Model. 2009 Dec;49(12):2749-60 PubMed

J Chem Inf Model. 2012 May 25;52(5):1250-61 PubMed

J Mol Graph. 1990 Mar;8(1):52-6, 29 PubMed

Nat Struct Biol. 2002 Dec;9(12):918-21 PubMed

Infect Immun. 2006 Dec;74(12):7035-9 PubMed

Biochem Soc Symp. 2002;(69):59-72 PubMed

Methods Enzymol. 1982;83:378-85 PubMed

FEBS Lett. 2003 Dec 4;555(2):297-301 PubMed

Mol Immunol. 2009 Dec;47(2-3):233-46 PubMed

Cell Microbiol. 2005 Apr;7(4):481-8 PubMed

Microbiology (Reading). 2005 May;151(Pt 5):1313-1323 PubMed

J Mol Biol. 1993 Dec 5;234(3):779-815 PubMed

Annu Rev Biophys Biomol Struct. 1995;24:551-77 PubMed

Annu Rev Cell Biol. 1993;9:237-64 PubMed

Proteins. 2013 Sep;81(9):1509-26 PubMed

J Am Chem Soc. 2008 Dec 17;130(50):16933-42 PubMed

FEBS Lett. 2006 Feb 6;580(3):982-7 PubMed

J Mol Recognit. 2011 Mar-Apr;24(2):149-64 PubMed

Biochem Soc Trans. 1996 Feb;24(1):146-50 PubMed

Proteins. 2005 Feb 15;58(3):735-46 PubMed

Chem Rev. 1998 Apr 2;98(2):637-674 PubMed

BMC Struct Biol. 2007 Jun 01;7:36 PubMed

Adv Exp Med Biol. 2003;535:17-32 PubMed

Biochim Biophys Acta. 2002 Sep 19;1572(2-3):165-77 PubMed

J Mol Graph Model. 2009 Jun-Jul;27(8):908-20 PubMed

Mol Microbiol. 2004 May;52(3):691-700 PubMed

J Chem Inf Model. 2008 Nov;48(11):2234-42 PubMed

Glycobiology. 2013 Feb;23(2):241-58 PubMed

J Cyst Fibros. 2004 Aug;3 Suppl 2:95-6 PubMed

J Comput Chem. 2002 Nov 15;23(14):1297-304 PubMed

Biochemistry. 2006 Jun 20;45(24):7501-10 PubMed

J Comput Chem. 2003 Dec;24(16):1999-2012 PubMed

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...